Schedule 13D ownership disclosure

Orthofix Medical Inc

Common stock, $0.10 par value per share · CUSIP: 68752M108

Event date: 2025-09-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Juniper Targeted Opportunity Fund, L.P.Reported CIK 0001524397

    Shares: 2,392,556.00 · Class: 6.1%

  • Juniper HF Investors II, LLC

    Shares: 2,392,556.00 · Class: 6.1%

  • Juniper Targeted Opportunities, L.P.Reported CIK 0001680619

    Shares: 407,124.00 · Class: 1.0%

  • Juniper Targeted Opportunity Investors, LLC

    Shares: 407,124.00 · Class: 1.0%

  • Juniper Multi-Strategy Fund, L.P.

    Shares: 45,426.00 · Class: 0.1%

  • Juniper HF Investors, LLC

    Shares: 45,426.00 · Class: 0.1%

  • Juniper Investment Company, LLCReported CIK 0001794034

    Shares: 2,845,106.00 · Class: 7.2%

  • Alexis P. MichasReported CIK 0001044005

    Shares: 2,845,106.00 · Class: 7.2%

  • John A. BartholdsonReported CIK 0001382909

    Shares: 2,845,106.00 · Class: 7.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-014209
Form type
SCHEDULE 13D/A
Filer
Juniper Investment Company, LLC
CIK
CIK 1794034
Filed
Sep 25, 2025
Reporting period
Sep 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub